SOL Mental Health has appointed its next CEO, ARC Health has acquired a California-based mental healthcare provider, and Ellie Mental Health and CODAC Behavioral Healthcare have made executive-level hires.

The American Medical Association has approved a CPT III code for psychedelic therapies submitted by COMPASS Pathways and MAPS Public Benefit Corporation, and Delix Therapeutics has initiated a phase I trial for a novel compound.

CVS Health announced it is adding mental health screenings to Project Health, its community-based program that offers a variety of free health assessments, primarily for low-income individuals and underserved populations.